Citation Impact
Citing Papers
Surveillance of the Tumor Mutanome by T Cells during Progression from Primary to Recurrent Ovarian Cancer
2013
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions
2014
High burden and pervasive positive selection of somatic mutations in normal human skin
2015 StandoutScience
Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells
2016
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer
2014
Mutational landscape and significance across 12 major cancer types
2013 StandoutNature
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
2017 StandoutNature
mRNA therapeutics in cancer immunotherapy
2021
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Cell type-selective secretome profiling in vivo
2020 StandoutNobel
High sensitivity of cancer exome-based CD8 T cell neo-antigen identification
2014
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Top 10 Challenges in Cancer Immunotherapy
2020
Circular RNAs are a large class of animal RNAs with regulatory potency
2013 StandoutNature
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
The European Regulatory Environment of RNA-Based Vaccines
2016
Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra- and paracellular pathways
2016
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
The biology and management of non-small cell lung cancer
2018 StandoutNature
Principles for designing an optimal mRNA lipid nanoparticle vaccine
2021
The landscape of mRNA nanomedicine
2022
Immunotherapy at Large: The road to personalized cancer vaccines
2013
PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis
2014
Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
2013
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
2014 Nature
Developing neoantigen-targeted T cell–based treatments for solid tumors
2019
Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response
2019
The cancer antigenome
2012
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
2014 StandoutNature
Personalized cancer vaccines: Targeting the cancer mutanome
2016
Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula
2014
A Trans-amplifying RNA Vaccine Strategy for Induction of Potent Protective Immunity
2019
Recent advances in mRNA vaccine technology
2020 StandoutNobel
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Evolving synergistic combinations of targeted immunotherapies to combat cancer
2015
Neutrophils escort circulating tumour cells to enable cell cycle progression
2019 Nature
Macrophages and Metabolism in the Tumor Microenvironment
2019
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival
2014
Induction of Cytomegalovirus-Specific T Cell Responses in Healthy Volunteers and Allogeneic Stem Cell Recipients Using Vaccination With Messenger RNA–Transfected Dendritic Cells
2014
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
2011 StandoutNobel
Drug delivery systems for RNA therapeutics
2022
Inflammation: the incubator of the tumor microenvironment
2022
Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study
2017
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
2022 StandoutNobel
mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma
2016
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
mRNA transcript therapy
2014 StandoutNobel
Oxidative Stress in Cancer
2020 Standout
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Translation of genomics-guided RNA-based personalised cancer vaccines: towards the bedside
2014
In situ T-cell transfection by anti-CD3-conjugated lipid nanoparticles leads to T-cell activation, migration, and phenotypic shift
2021
Therapeutic vaccines for cancer: an overview of clinical trials
2014
An RNA-Seq Strategy to Detect the Complete Coding and Non-Coding Transcriptome Including Full-Length Imprinted Macro ncRNAs
2011
Discovery and saturation analysis of cancer genes across 21 tumour types
2014 StandoutNature
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
2019
Targeting the tumor mutanome for personalized vaccination therapy
2012
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
mRNA Cancer Vaccines
2016
The Unexpected Importance of the Primary Structure of the Hydrophobic Part of One-Component Ionizable Amphiphilic Janus Dendrimers in Targeted mRNA Delivery Activity
2022 StandoutNobel
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
2023 StandoutNobel
Targeted and Equally Distributed Delivery of mRNA to Organs with Pentaerythritol-Based One-Component Ionizable Amphiphilic Janus Dendrimers
2023 StandoutNobel
Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity
2014
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia
2014
Coinhibitory Pathways in Immunotherapy for Cancer
2016
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics
2019
DeepLigand: accurate prediction of MHC class I ligands using peptide embedding
2019
Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
2013
HLA-Binding Properties of Tumor Neoepitopes in Humans
2014
The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
2016
A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs
2013
Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma
2017
Peptide-binding specificity prediction using fine-tuned protein structure prediction networks
2023 StandoutNobel
IL-27 gene therapy induces depletion of Tregs and enhances the efficacy of cancer immunotherapy
2018
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2016 Standout
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
2022 StandoutScienceNobel
The 'anti-hype' vaccine
2017
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Metabolic reprogramming and cancer progression
2020 StandoutScience
Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines
2016
Cancer Genome Landscapes
2013 StandoutScience
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
A systematic dissection of determinants and consequences of snoRNA-guided pseudouridylation of human mRNA
2022 StandoutNobel
Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers
2021 StandoutNobel
Regulatory Role of Small Nucleolar RNAs in Human Diseases
2015
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Neoantigen landscape dynamics during human melanoma–T cell interactions
2016 Nature
Neoantigens in cancer immunotherapy
2015 StandoutScience
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines
2023 StandoutNobel
Therapeutic cancer vaccines
2015
Small RNAs with big implications: new insights into H/ACA snoRNA function and their role in human disease
2014
Personalized vaccines for cancer immunotherapy
2018 Science
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
Works of Martin Löwer being referenced
Exploiting the Mutanome for Tumor Vaccination
2012
HLA typing from RNA-Seq sequence reads
2012
Response definition criteria for ELISPOT assays revisited
2010
Digital Genome-Wide ncRNA Expression, Including SnoRNAs, across 11 Human Tissues Using PolyA-Neutral Amplification
2010
Myeloid Cell-Derived Reactive Oxygen Species Induce Epithelial Mutagenesis
2017
Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3′ UTRs Identified by Cellular Library Screening
2018
Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution
2017
Confidence-based Somatic Mutation Evaluation and Prioritization
2012
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
2015 Nature
Mutanome Engineered RNA Immunotherapy: Towards Patient-Centered Tumor Vaccination
2015